Bernhard Mueller
20Patents
5h-index
47Co-inventors
69Inventor score
Filing activity: Dec 21, 2001 → Sep 25, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9109026B2 | Dual variable domain immunoglobulins and uses thereof | Emerging Cross-Sectional Technologies | 25 | Active |
| US7981420B2 | Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) | Human Necessities | 21 | Expired |
| US7771952B2 | Modulators and modulation of the interaction between RGM and Neogenin | Emerging Cross-Sectional Technologies | 8 | Expired |
| US8680239B2 | Use of RGM and its modulators | Human Necessities | 6 | Active |
| US9102722B2 | Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration | Physics | 5 | Active |
| US10118958B2 | Composition and method for the diagnosis and treatment of iron-related disorders | Chemistry; Metallurgy | 3 | Active |
| US8445686B2 | 4-(4-pyridinyl)-benzamides and their use as rock activity modulators | Chemistry; Metallurgy | 3 | Active |
| US10822403B2 | Composition and method for the diagnosis and treatment of iron-related disorders | Chemistry; Metallurgy | 2 | Active |
| US10106602B2 | Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof | Physics | 1 | Active |
| US8962803B2 | Antibodies against the RGM A protein and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9636398B2 | Composition and method for the diagnosis and treatment of iron-related disorders | Physics | 1 | Active |
| US12098192B2 | Composition and method for the diagnosis and treatment of iron-related disorders | Chemistry; Metallurgy | 1 | Active |
| US9365643B2 | Antibodies that bind to repulsive guidance molecule A (RGMA) | Physics | 1 | Active |
| US9605069B2 | Antibodies against the RGM a protein and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US12098189B2 | Composition and method for the diagnosis and treatment of iron-related disorders | Chemistry; Metallurgy | 1 | Active |
| US9175075B2 | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein | Chemistry; Metallurgy | 1 | Active |
| US7906120B2 | Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) | Emerging Cross-Sectional Technologies | 0 | Active |
| US9255146B2 | Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12365729B2 | Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis | Chemistry; Metallurgy | 0 | Active |
| US10040852B2 | Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.